The price of Agilon Health Inc (NYSE:AGL) shares last traded on Wall Street rose 1.49% to $5.46.
AGL stock price is now -5.78% away from the 50-day moving average and -56.50% away from the 200-day moving average. The market capitalization of the company currently stands at $2.24B.
With the price target of $5, Barclays recently initiated with Underweight rating for Agilon Health Inc (NYSE: AGL). On February 26, 2024, TD Cowen Downgraded its previous ‘Outperform’ rating to ‘Market Perform’ on the stock reducing its target price from $12 to quote $6.50, while ‘Jefferies’ rates the stock as ‘Hold’
In other news, Schwaneke Jeffrey A., Director bought 22,300 shares of the company’s stock on Nov 29 ’23. The stock was bought for $250,206 at an average price of $11.22. Upon completion of the transaction, the Director now directly owns 31,931 shares in the company, valued at $0.17 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 13 ’23, Chief Markets Officer Shaker Benjamin sold 18,750 shares of the business’s stock. A total of $337,455 was realized by selling the stock at an average price of $18.00. This leaves the insider owning 79,543 shares of the company worth $0.43 million. A total of 26.12% of the company’s stock is owned by insiders.
During the past 12 months, Agilon Health Inc has had a low of $4.41 and a high of $28.38. As of last week, the company has a debt-to-equity ratio of 0.08, a current ratio of 1.51, and a quick ratio of 1.51.
The net profit margin was -4.72% and return on equity was -23.40% for AGL. The company reported revenue of $815.5 million for the quarter, compared to $369.78 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 120.54 percent.
